Not every importer should sell their IEEPA tariff refund claim. But there are three scenarios where the math clearly favors immediate capital over government timelines. The Supreme Court’s 6-3 decision in Learning Resources v. Trump (February 2026) created a $166 billion refund pool covering duties collected under HTS headings 9903.01 and 9903.02 between February 2025 and February 2026. CBP must now return those funds through the CAPE portal — but the timeline remains uncertain, and the administrative burden is significant.
Scenario 1: High Opportunity Cost
A manufacturer with $2M in IEEPA claims can deploy capital at 25% annual returns through inventory expansion. Waiting 24 months for full government recovery yields $2M. Selling at a discount and deploying the proceeds at 25% for two years may yield significantly more than the original claim value.
The discount is more than offset by productive deployment. The key variable is your return on deployed capital. For importers with strong reinvestment opportunities — expansion into new markets, bulk purchasing at favorable terms, equipment upgrades — the time value of money makes waiting the more expensive option. The discount to face value is not a loss; it is the cost of accelerating capital into a higher-yield use.
Consider a concrete example under 19 USC 1505(c): a $5M claim filed in early 2025 accrues statutory interest, but if CBP processing takes 30 months, the importer foregoes deploying that $5M into a supply chain expansion that generates 20% annual margin. The opportunity cost of waiting dwarfs the discount embedded in a non-recourse acquisition offer. Importers who can redeploy capital into revenue-generating operations should evaluate the full valuation methodology before assuming that holding is the optimal strategy.
Scenario 2: Cash Flow Constraints
An importer facing seasonal working capital demands needs $500K for inventory before Q4. The IEEPA claim is real but the government timeline extends well past the seasonal window. Selling provides liquidity exactly when it generates the most business value.
Cash flow timing is often more important than absolute recovery amount. A dollar today funds tomorrow’s revenue. A dollar in 18 months funds nothing until it arrives. This is particularly acute for importers who rely on credit facilities tied to inventory cycles — deploying claim proceeds into working capital can reduce borrowing costs while simultaneously funding growth.
For importers in this position, a partial assignment may be the optimal structure: sell enough entries to cover the immediate need, retain the rest for full government recovery. The ACE system allows entry-level data export, which means each entry can be independently valued and assigned. CBP processes entries individually, not as portfolios, so splitting a claim into sold and retained portions creates no administrative complication.
Working with a licensed customs broker — many of whom participate in the partner program at tariffpartners.com — ensures the data export is clean and complete. The broker pulls the ES-003 report, we validate against IEEPA-affected HTS codes, and the importer decides which entries to monetize.
Scenario 3: Risk-Adjusted Processing Uncertainty
CAPE has never processed a recovery event at this scale. The system remains under development. Processing order depends on filing position among 330,000 importers. Interest calculations under 19 USC 1505(c) are unsettled. The administrative complexity of managing entries across multiple brokers, tariff programs, and HTS classifications adds further uncertainty.
CBP has approximately 2,500 staff responsible for processing 53 million entry lines. Even under optimistic assumptions, full disbursement will take years. The queue position risk alone introduces meaningful variance into any present-value calculation. Importers who filed early may see faster processing, but there is no published priority framework and no binding timeline from CBP.
For risk-averse importers, eliminating all government dependency through a non-recourse sale provides certainty that no amount of waiting can match. The discount to face value is the price of that certainty. Every risk — processing delays, system failures, queue position, partial adjustments, regulatory changes — transfers entirely to the buyer at closing. The seller walks away with capital in hand and zero exposure to government timelines. To understand exactly what transfers and what the seller retains, see what non-recourse actually covers.
The Middle Ground
These scenarios are not mutually exclusive. Many importers face some combination of opportunity cost, cash constraints, and risk aversion. Our seller’s guide offers a middle path — sell enough entries to fund immediate needs while retaining the rest for full government recovery.
For importers who want to evaluate all four recovery paths — government self-filing, broker-assisted recovery, CIT litigation, and claim sale — tariffresolution.com provides comprehensive assessments. Not sure whether your entries qualify? The free screening tool at tariffrefundchecker.com can help determine eligibility in minutes.
Request a confidential Impact Assessment to see what your claim is worth and which structure fits your situation.